(searched for: 10.29328/journal.japch.1001044)
Published: 4 January 2022
Journal of Advanced Pediatrics and Child Health, Volume 5, pp 001-003; https://doi.org/10.29328/journal.japch.1001044
Brimonidine tartrate eye drops are a topical agent used to treat glaucoma in children over 2 years of age and adults. It is banned for children younger than 2 years of age because post-marketing studies have shown serious side effects. Colic is common in infants, which worries parents. And parents often use herbal and chemical medicines to solve this problem. We present a 12-day-old newborn with brimonidine eye drop intoxication, in which the drug was mistakenly administered orally to treat the colic problem.